Clinical trials
Recruiting Carcinoma, Non-Small-Cell Lung trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
91 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 7 |
| 2023 | 9 |
| 2024 | 18 |
| 2025 | 35 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 91 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 9 |
| Bristol-Myers Squibb | 7 |
| BioNTech SE | 6 |
| AstraZeneca | 4 |
| Cancer Research UK | 4 |
| AbbVie | 3 |
| Eli Lilly and Company | 3 |
| Janssen Research & Development, LLC | 3 |
| Pfizer | 3 |
| Seagen, a wholly owned subsidiary of Pfizer | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 91 |
| Lung Neoplasms | 19 |
| Colorectal Neoplasms | 16 |
| Ovarian Neoplasms | 13 |
| Neoplasms | 12 |
| Squamous Cell Carcinoma of Head and Neck | 11 |
| Stomach Neoplasms | 11 |
| Triple Negative Breast Neoplasms | 10 |
| Pancreatic Neoplasms | 7 |
| Carcinoma | 6 |
Trials
Showing 1 to 25 of 91. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.